In the News January 5, 2020

The Pink Sheet | US FDA Getting Faster at Notifying Drug Facility Owners of Inspection Status

Cathy Burgess is referenced for commenting at a Food and Drug Law Institute conference on the timing for declaring a drug manufacturing facility as “official action indicated” following inspection by the U.S. Food and Drug Administration.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.